Invention Grant
- Patent Title: SMAC peptidometics useful as IAP inhibitors
- Patent Title (中): SMAC肽酶用作IAP抑制剂
-
Application No.: US13606676Application Date: 2012-09-07
-
Publication No.: US08546336B2Publication Date: 2013-10-01
- Inventor: Zhuoliang Chen , Mark G. Charest , Christine Hiu-Tung Chen , Miao Dai , Feng He , Huangshu Lei , Ly Luu Pham , Sushil Kumar Sharma , Christopher Sean Straub , Run-Ming David Wang , Fan Yang , Leigh Zawel
- Applicant: Zhuoliang Chen , Mark G. Charest , Christine Hiu-Tung Chen , Miao Dai , Feng He , Huangshu Lei , Ly Luu Pham , Sushil Kumar Sharma , Christopher Sean Straub , Run-Ming David Wang , Fan Yang , Leigh Zawel
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Arlene K. Musser
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The present invention is directed to a compound of the formula: or pharmaceutically acceptable salts thereof and use of such compounds for treating proliferative diseases such as cancer, in mammals.
Public/Granted literature
- US20130005663A1 SMAC PEPTIDOMETICS USEFUL AS IAP INHIBITORS Public/Granted day:2013-01-03
Information query
IPC分类:
